编号 |
产品名称 |
CAS号 |
规格 |
价格 |
|
| CM-13576 |
Ym 201636
YM-201636 ≥95% |
371942-69-7 |
|
|
| CM-10518 |
3,4-Methylenedioxy Pyrovalerone metabolite 1 HCl ≥95%
3,4-Methylenedioxy Pyrovalerone metabolite 1 HCl ≥95% |
NA |
|
|
| CM-11314 |
盐酸白屈菜红碱
Chelerythrine (chloride) ≥98% |
3895-92-9 |
|
|
| CM-70290 |
萘普生
(S)-Naproxen ≥99% |
22204-53-1 |
|
|
| CM-15321 |
硫酸卡那霉素
Kanamycin A (sulfate) ≥98% |
25389-94-0 |
|
|
| CM-60972 |
D-myo-Inositol-1,3,4-triphosphate sodium salt ≥98%
D-myo-Inositol-1,3,4-triphosphate sodium salt ≥98% |
NA |
|
|
| CM-08663 |
LY2183240 ≥98%
LY2183240 ≥98% |
874902-19-9 |
|
|
| CM-16154 |
CH 223191 ≥95%
CH 223191 ≥95% |
301326-22-7 |
|
|
| CM-13316 |
生物素化-epsilon-氨基己酸-N-羟基丁二酰亚胺活化酯
Biotin-X-NHS ≥95% |
72040-63-2 |
|
|
| CM-10670 |
Heneicosapentaenoic Acid ≥95%
Heneicosapentaenoic Acid ≥95% |
24257-10-1 |
|
|
| CM-12022 |
()-WIN 55,212-3 (mesylate) ≥98%
()-WIN 55,212-3 (mesylate) ≥98% |
131543-25-4 |
|
|
| CM-15664 |
Jwh-019
JWH 019 (豁免的制备) ≥98% |
209414-08-4 |
|
|
| CM-90200 |
5,8,11-十二烯酸
5,8,11-Eicosatriynoic Acid ≥99% |
13488-22-7 |
|
|
| CM-16208 |
1-甲基-5-硝基-2-羟甲基咪唑
Hydroxy Dimetridazole ≥98% |
936-05-0 |
|
|
| CM-07958 |
C-12 NBD Ceramide ≥98%
C-12 NBD Ceramide ≥98% |
202850-01-9 |
|
|
| CM-11634 |
纳他霉素
Natamycin ≥95% |
7681-93-8 |
|
|
| CM-10681 |
N-棕榈酰神经鞘氨醇
C-16 Ceramide ≥98% |
24696-26-2 |
|
|
| CM-13530 |
Bicyclo Prostaglandin E1 >98%
Bicyclo Prostaglandin E1 >98% |
NA |
|
|
| CM-06594 |
氯沙坦钾
Losartan (potassium salt) ≥98% |
124750-99-8 |
|
|
| CM-11492 |
N-[4-[(3-氯-4-氟苯基)氨基]-7-[[(3s)-四氢-3-呋喃]氧基]-6-喹唑啉]-4-(二甲基氨基)-2-丁酰胺
BIBW 2992 ≥95% |
439081-18-2 |
|
|
